Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair

Completed · Phase 2

Conditions studied: Asthma

In brief

To examine the post-dose changes in exhaled Nitric Oxide (eNO) following treatment with inhaled Advair in subjects with chronic but stable asthma as defined in Global Initiative for Asthma (GINA) guidelines.

Key facts

Study ID

NCT00927758

Run by

Sandoz

People needed

105

Starts

2009-06-01

Expected to finish

2009-12-01

Last updated by the study team

2017-03-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• must be able to speak, read, and understand English
• exhaled Nitrous Oxide levels must be greater than or equal to 60 ppb at screening and greater than or equal to 55 ppb at Visits 2, 9, and 16
• must have history of at least 6 months of chronic, but stable asthma
• except for the presence of asthma, subjects must be in general good health

You may not qualify if…

• past or present history of experiencing allergic reaction to medications used in this study
• subjects must not be receiving ongoing regular treatment with inhaled corticosteroids
• subjects must not have ragweed allergy
• subjects must have no recent history of respiratory infections for at least 1 month prior to screening and until the end of the study

Where it is running

• University of Florida — Gainesville, Florida, United States
• CompleWare — Iowa City, Iowa, United States
• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.